We further confirmed the presence of myeloid_MKI67 cells in a dataset collating hormone receptor-positive and triple-negative breast cancers from patients who received neoadjuvant therapy with anti-PD1 antibodies46 (Figure 8G). The gene discussed is PDCD1; the disease is triple-negative breast carcinoma.